LeserbriefKommentar
Methodological concerns for ultra-hypofractionated neoadjuvant radiation therapy in soft tissue sarcoma
Radiotherapy and Oncology · 2023
DOI: 10.1016/j.radonc.2023.109596 ↗Kurz gefasst
Leserbrief in der Zeitschrift Radiotherapy and Oncology, 2023. Verfasst von Shu-Wei Hsu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Tainan, Taiwan. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
SarcomaSoft Tissue NeoplasmsHumansNeoadjuvant TherapyCombined Modality Therapy
Autor:innen und Institutionen
- Independent Researcher, Tainan, Taiwan.
- Department of Radiation Oncology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan. Electronic address: codingforlifetime@gmail.com.
Zitieren
APA
Hsu, S. W., & Kao, Y. S. (2023). Methodological concerns for ultra-hypofractionated neoadjuvant radiation therapy in soft tissue sarcoma. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2023.109596
Vancouver
Hsu SW, Kao YS. Methodological concerns for ultra-hypofractionated neoadjuvant radiation therapy in soft tissue sarcoma. Radiotherapy and Oncology. 2023. doi:10.1016/j.radonc.2023.109596
BibTeX
@article{Hsu2023,
author = {Hsu, Shu-Wei and Kao, Yung-Shuo},
title = {Methodological concerns for ultra-hypofractionated neoadjuvant radiation therapy in soft tissue sarcoma},
journal = {Radiotherapy and Oncology},
year = {2023},
doi = {10.1016/j.radonc.2023.109596}
}
EUVIMED